Psoriasis: presentation, diagnosis and management An overview of psoriasis, including its clinical features, diagnosis and management, as well as how pharmacists can optimise care.…
Test your knowledge of musculoskeletal conditions Our self-assessment quiz on musculoskeletal conditions covers the more common disorders that pharmacy staff may encounter, from arthritis and gout to carpal tunnel syndrome.…
JAK inhibitors: risks and safety principles An overview of the mechanism of action of Janus kinase inhibitors, as well as the risks and common side effects of their use in treating chronic inflammatory disorders.…
Health news round-up: puberty blockers, oral GLP-1s and inequalities in neonatal care A weekly summary of important developments in pharmacy and health news that you may have missed.…
NICE recommends first licensed treatment for vitiligo Guidance says that ruxolitinib cream can be used as treatment for vitiligo if other first-line treatments — such as including topical corticosteroids and light therapy — do not work.…
Health news round-up: GLP-1s for psoriasis, promise for people with cancer and pharmacogenomics A weekly summary of important developments in pharmacy and health news that you may have missed.…
Everything you need to know about mpox Following the identification of a new strain in England — and an ongoing global outbreak of the most severe subgroup of mpox — here is a summary of the latest information and best practice for pharmacy professionals.…
Health news round-up: NICE approvals, surveillance data and GLP-1 warnings A weekly summary of important developments in pharmacy and health news that you may have missed.…
PJ view: Access to rare disease treatment should not be a rarity Policymakers and healthcare leaders must persevere with long overdue changes to improve access to treatments for rare diseases.…
Is a cure for epidermolysis bullosa on the horizon? New trials to repurpose drugs for the rare genetic skin condition epidermolysis bullosa are offering families a level of hope not seen before, raising the question of whether a cure may finally be in sight.…
